Sublingual sufentanil for incident pain and dementia-related response agitation

International Psychogeriatrics

Volumn 23, Issue 5, 2011, Pages 844-846

  Passmore, Michael J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

aggression; Alzheimer's disease; behavior; BPSD; nursing; opioid; palliative care

Indexed keywords

LORAZEPAM; LOXAPINE; PARACETAMOL; QUETIAPINE; SUFENTANIL;

AGED; AGGRESSION; AGITATION; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; LOW DRUG DOSE; PAIN; PALLIATIVE THERAPY; REMISSION; SYMPTOM; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALGESICS, OPIOID; FEMALE; HIP FRACTURES; HUMANS; PAIN, POSTOPERATIVE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR AGITATION; SUFENTANIL; TREATMENT OUTCOME;

EID: 79956037599     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610211000275     Document Type: Article

References (8)

1. Herrmann, N. and Gauthier, S. (2008). Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease. Canadian Medical Association Journal, 179, 1279-1287.
2. Kunik, M. E. et al. (2010). Causes of aggressive behavior in patients with dementia. Journal of Clinical Psychiatry, 71, 1145-1152.
3. Palmer, P. P., Hamel, L. G. and Skowronski, R. J. (2009). Single- and repeat-dose pharmacokinetics of sublingual sufentanil nanotab in healthy volunteers. Poster A1222 - Proceedings of the 2009 Annual Meeting of the American Society Anesthesiologists. New Orleans, 17-21 October.
4. Passmore, M. J., Gardner, D. M., Polak, Y. and Rabheru, K. (2008). Alternatives to atypical antipsychotics for the management of dementia-related agitation. Drugs and Aging, 25, 381-398. (Pubitemid 351629665)
5. Reisfield, G. M. and Wilson, G. R. (2007). Rational use of sublingual opioids in palliative medicine. Journal of Palliative Medicine, 10, 465-475. (Pubitemid 46740220)
6. Sampson, E. L. et al. (2011). Palliative assessment and advance care planning in severe dementia: an exploratory randomized controlled trial of a complex intervention. Palliative Medicine [e-journal] 12 January 2011.
7. Scholz, J., Steinfath, M. and Schulz, M. (1996). Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update. Clinical Pharmacokinetics, 31, 275-279.
8. US Food and Drug Administration (2005). Public Health Advisory. Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances. 11 April. Silver Spring, MD: Food and Drug Administration.